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Background: Community engagement in research has gained momentum as an approach to improving research,
to helping ensure that community concerns are taken into account, and to informing ethical decision-making
when research is conducted in contexts of vulnerability. However, guidelines and scholarship regarding community
engagement are arguably unsettled, making it difficult to implement and evaluate.
Discussion: We describe normative guidelines on community engagement that have been offered by national and
international bodies in the context of HIV-related research, which set the stage for similar work in other health
related research. Next, we review the scholarly literature regarding community engagement, outlining the diverse
ethical goals ascribed to it. We then discuss practical guidelines that have been issued regarding community
engagement. There is a lack of consensus regarding the ethical goals and approaches for community engagement,
and an associated lack of indicators and metrics for evaluating success in achieving stated goals. To address these
gaps we outline a framework for developing indicators for evaluating the contribution of community engagement
to ethical goals in health research.
Summary: There is a critical need to enhance efforts in evaluating community engagement to ensure that the
work on the ground reflects the intentions expressed in the guidelines, and to investigate the contribution of
specific community engagement practices for making research responsive to community needs and concerns.
Evaluation mechanisms should be built into community engagement practices to guide best practices in community
engagement and their replication across diverse health research settings.
Keywords: Research ethics, Community engagement, Participatory research, Global health, Evaluation, MetricsBackground
Community engagement in research has gained mo-
mentum as an approach to improving research, to
helping ensure that community concerns are taken into
account, and to informing ethical decision-making
when research is conducted in contexts of vulnerability
[1–3]. The term community generally denotes a group
of people with some kind of shared social identity, while
the term engagement indicates an interactive relation-
ship between a community and a research entity. The
phrase community engagement has been used to describe
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creativecommons.org/publicdomain/zero/1.0/National and international bodies now recognize the
importance of community engagement in research. For
example, the Wellcome Trust [4] and the Bill and Melinda
Gates Foundation [5, 6] have provided funding to examine
the ethical aspects of community engagement in inter-
national research. The US National Institutes of Health
(NIH) has supported community-engaged research
through its Clinical and Translational Science Award
(CTSA) program and the NIH Division of AIDS (DAIDS)
provides core funding to support community engagement
via its research networks [7]. Further, major international
research efforts such as H3Africa have embedded
community engagement efforts [8]. A review of inter-
national ethics guidance documents published in 2004
identified community engagement to be a central guid-
ing principle [9]. Interestingly, a review published by
the same group four years earlier, which did not havess article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
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community engagement as a guiding principle [10], sug-
gesting a view that community engagement was essential
in particular settings and/or a rather rapid emergence of
global consensus on its importance.
Despite such broad support, guidelines and scholar-
ship regarding community engagement are arguably un-
settled [11], which can make it difficult to implement
and assess, potentially resulting in missed opportunities,
wasted resources and poor decisions. In this paper we
first describe normative guidelines on community en-
gagement that have been offered by national and inter-
national bodies in the context of HIV-related research,
which set the stage for similar work in other health re-
lated research. Next, we review the scholarly literature
regarding community engagement, outlining the diverse
ethical goals ascribed to it. We then discuss practical
guidelines that have been issued regarding community
engagement, the lack of consensus regarding their
ethical goals and approaches, and the associated lack of
indicators and clear metrics for evaluating success in
achieving such goals. We then offer a framework for
developing indicators as a critical step toward evaluating
community engagement in health research.
Discussion
Guidelines on community engagement
Statements of principle in HIV-related research
Since early in the AIDS pandemic, substantial attention
has focused on community engagement in HIV related
research, with several national and international bodies
offering particular guidelines for this purpose. Following
an extensive two-year global consultation process UNAIDS
in 2000 put forward a comprehensive set of guidelines for
the implementation of HIV vaccine trials that referenced
community participation. Guidance Point 5 stated that
“community representatives should be involved in an
early and sustained manner in the design, development,
implementation, and distribution of results of HIV
vaccine research” that included establishment of “a
continuing forum for communication and problem-
solving”[12](p. 19). In the updated and expanded 2007
Ethical Considerations in Biomedical HIV Prevention
Trials, the language was refined and the need for com-
munity engagement received increased emphasis:
Guidance Point 2: Community Participation
To ensure the ethical and scientific quality and
outcome of proposed research, its relevance to the
affected community, and its acceptance by the affected
community, researchers and trial sponsors should
consult communities through a transparent and
meaningful participatory process which involves themin an early and sustained manner in the design,
development, implementation, monitoring, and
distribution of results of biomedical HIV prevention
trials [13].
Also in 2007, UNAIDS and AVAC (a global advocacy
organization for HIV prevention research) jointly authored
the Good Participatory Practice Guidelines for Biomedical
HIV Prevention Trials (GPP-HIV). Revised in 2011,
GPP-HIV includes guiding principles for implementation
of community and stakeholder engagement [14]. Subse-
quently, the Stakeholder and Community Engagement
Workgroup of the Critical Path to TB Drug Regimens col-
laborated with AVAC to adapt GPP-HIV for tuberculosis
(TB) research, releasing the Good Participatory Practice
Guidelines for TB Drug Trials (GPP-TB) in 2012 [15, 16].
The importance of community engagement as a cross-
cutting ethical issue for HIV, TB and malaria vaccine trials
was underscored in a report from a 2009 consultation
sponsored by the Ethics, Law and Human Rights Collab-
orating Centre of the WHO/UNAIDS African AIDS Vac-
cine Programme [17].
In 2009 the HIV Prevention Trials Network’s (HPTN)
ethics guidance for research [18], directly addressed
community engagement as an ethical obligation in guid-
ance point 3:
In order to ensure that HPTN research is appropriate
as well as scientifically and ethically sound, relevant
communities will be engaged in a meaningful process
that will help guide the research from protocol
development to dissemination of results.
Guidance point 4, framed as aspirational, separately
addressed local capacity-building and establishing part-
nerships within local communities.
Community engagement has been explicitly incorpo-
rated into some national guidelines for clinical research
broadly and HIV research specifically. For example,
South Africa’s National Health Research Ethics Council’s
Guidelines for Good Practice in the Conduct of Clinical
Trials with Human Participants in South Africa recom-
mended that research ethics committees require investi-
gators to provide plans to consult with community
representatives as well as involve communities during
the research and in disseminating research findings from
the study. The guidelines note the importance of invo-
lving communities in research when they are deemed
“vulnerable” and explicitly require community involve-
ment in the design and conduct of population-focused
HIV prevention research [19]. The Guidelines further
recommend that sponsors establish community advisory
groups (CAGs) for research carried out at a community
level (e.g., vaccine trials) as a means to “ensure adequate
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within affected communities at all phases of the trial”
[19](page 29).
Scholarly discourse
In tandem with the promulgation of ethics guidelines, a
rich discussion about the ethical goals of community
engagement can be found in the scholarly literature, as
outlined in Table 1.
Building on a history of community engagement in
public health practice and growing attention to commu-
nity engagement in research, in 2000, Weijer and Emanuel
argued that the ethical goal of community engagement in
research was to protect communities [20]. They recom-
mended a variety of processes by which such protection
could be realized, largely based on the characteristics of
the community or communities involved in the research
in question. In 2004, Emanuel and co-authors listed
“collaborative partnership” as one of the eight criteria
for ethical research in developing country settings. They
argued that collaborative partnership with the commu-
nity minimizes the possibility of exploitation, increases
the likelihood that the research will have a long-term
impact, and demonstrates an awareness of and respect
for cultural differences between the researchers, spon-
sors and communities [9]. Another criterion listed was
“respect for recruited participants and study popula-
tions,” which includes, among other things, the require-
ment that researchers inform participants and the
community if new information arises during the course
of the research and develop strategies to inform com-
munities of the results of the research.
Though community consultation may be conceived of
as a narrow form of community engagement in research,
the underlying motivations for undertaking each are simi-
lar if not the same [6]. In 2005, Dickert and Sugarman
articulated ethical goals for community consultation
including enhanced protection, enhanced benefits, legit-
imacy, and shared responsibility for the conduct of the
research [21].
In 2007 Tindana and co-authors [6] summarized the
goals of community engagement from a number of
sources including the National Bioethics Advisory Com-
mission [2], the Nuffield Council on Bioethics [22], and
the Council for International Organizations of Medical
Sciences [23]. In general, they found that the ethical
goals of community engagement were described in terms
of a concern for the well-being of communities and pro-
tection of their interests, including fair representation of
communities in projects; attention to equitable partici-
pation in partnerships and the research process; fair
distribution of the benefits of research; and shared re-
sponsibility for the conduct of the research. They also
noted that the extant guidance generally indicated why,from an ethical perspective, communities should be
engaged in research: for their benefit, to reduce harms,
and to result in more appropriate research. More re-
cently, King and colleagues have proposed a universal
framework that emphasizes the “human infrastructure”
of relationships between researchers and communities
and aligns community engagement goals with three core
ethical responsibilities: (1) identifying and managing non-
obvious risks and benefits; (2) expanding respect beyond
the individual to the stakeholder community; and (3)
building legitimacy for the research project [24].
A Community Engagement and Consent Workshop
held in Kilifi, Kenya, in 2011 brought together groups
engaged in research and practice on community engage-
ment and informed consent from across the globe and
with a wide diversity of disciplinary backgrounds. The
workshop resulted in a critical examination of the
characterization, conduct, and evaluation of community
engagement and consent processes in diverse health
research contexts [11]. This examination highlighted the
lack of clarity in the range and scope of goals claimed
for community engagement, noting that they “can be
broadly divided into those that are more instrumental,
such as engaging communities to improve the quality of
research (or simply satisfying funders), and those that are
more intrinsic such as engaging communities to show
respect or to ensure a sense of inclusion” [11] (p. 9).
Workshop participants identified a range of interrelated
reasons for greater clarity of community engagement goals
in research, including potential tensions between differing
aims, the potential for negative impacts including unin-
tended perverse outcomes, and the limits to the ethical
issues that community engagement “can resolve in re-
search, including those related to historical and back-
ground injustices and inequities and poorly resourced
health systems” (p. 10). They highlighted the importance
of considering goals before and throughout studies to sup-
port planning and evaluation of community engagement
activities.
Practical guidance
In parallel with the scholarly literature regarding com-
munity engagement, those engaged in research have
articulated practical guidance. Early examples tended to
focus heavily on Community Advisory Boards (CABs) as
a mechanism to address ethical challenges and minimize
lapses related to, for example, meeting informed consent
requirements and contextual meanings of risks and
benefits [25–27]. However, the limitations of CABs have
also been increasingly noted including challenges in
assuring appropriate representation, mitigating power
imbalances, and balancing CAB independence with
research-based support [28]. CABs are now commonly
complemented by and balanced with other forms of
Table 1 Ethical goals of community engagement (listed
chronologically by publication date)
Weijer and Emanuel, 2000 [20]
Protect communities in research
Emanuel et al., 2004 [9]
Minimize the possibility of exploitation
Increase the likelihood that the research will have a long-term impact
Demonstrate an awareness of and respect for cultural differences
between the researchers, sponsors and communities
Respect for recruited participants and study populations
Dickert and Sugarman, 2005 [21]
Enhance protections for communities
Enhance benefits for communities
Enhance legitimacy for the research
Partners share responsibility for the conduct of the research
Nuffield Council of Bioethics, 2005 [53]
Enhance respect for communities
Tailor research to better meet the needs of communities
Tindana et al., 2007 [6]
Ensure the relevance of research
Assess whether relevant research is culturally and practically
acceptable in the context it is intended
Ensure that community disruption is minimized, i.e., avoiding the
displacement of local medical staff from pressing local needs
Avoid exploitation, by ensuring a fair distribution of the benefits of
research
Take into account the ethical hazards that may be part of the social,
economic, and political landscape of the community
Ahmed and Palermo, 2010 (COPR) [1]
Communities and investigators share power and responsibility
equitably
Diverse perspectives and populations are included in an equitable
manner
The research project results in mutual benefit for all partners
All partners receive equal respect
UNAIDS and AVAC, 2011 [14]
Ensure the ethical and scientific quality and outcome of proposed
research
Ensure relevance of research to the affected community
Ensure acceptance of research by the affected community
Participants in the Community Engagement Consent Workshop, Kilifi
Kenya [11]
Support research that is respectful to individuals and communities
where social value is maximized
Critical Path to TB Drug Regimens, 2012 [15]
Ensure that disparities and inequalities are not inadvertently
replicated or reinforced
Ensure that power dynamics do not disadvantage some stakeholders
more than others (minimize the threat of exploitation)
Ensure that the burden associated with TB drug trials is fully
apprehended and protocols are adjusted to minimize the burden
Table 1 Ethical goals of community engagement (listed
chronologically by publication date) (Continued)
Prioritize the management of stigma and involuntary isolation
Ensure emerging challenges are addressed in the new era of TB drug
trials
King, et al., 2014 [24]
Identifying and managing non-obvious risks and benefits
Expanding respect beyond the individual to the stakeholder
community
Building legitimacy for the research project
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community voices, perspectives and concerns to the
forefront including the use of traditional community
assemblies [29], qualitative research [30–33], and delib-
erative engagement processes [34].
In 2009, the National Institute of Allergy and Infec-
tious Diseases (NIAID), NIH, published a report, Recom-
mendations for Community Involvement in National
Institute of Allergy and Infectious Diseases HIV/AIDS
Clinical Trials Research. The report described principles
of community engagement, adapted from a 1997 report
of the United States Centers for Disease Control and
Prevention (CDC) and Agency for Toxic Substances and
Disease Registry (ATSDR) Committee on Community
Engagement [35]. The NIAID recommendations apply
particularly to CABs, indicating that CAB members are
expected to provide community input into the research
and foster a partnership between researchers and the
communities in which and with whom the research is
being conducted [3]. The recommendations delineate
the different roles and responsibilities of CAB members at
different levels of the research enterprise including the
international research network level as well as the local
research site. The 1997 CDC/ATSDR guidelines were ex-
tensively updated in 2011 in collaboration with the Clinical
and Translational Science Awards Consortium [36]; and in
2014 an updated version of the NIAID report was devel-
oped by Community Partners, a global group of commu-
nity representatives affiliated with the HIV/AIDS clinical
trials networks funded by the National Institutes of Health
(NIH), in collaboration with NIAID [37].
The NIH’s Council of Public Representatives (COPR),
which provides advice to the Director of the NIH, in
2010 developed frameworks for community engagement
in research education (including research values, strat-
egies to operationalize each value, and potential out-
comes of their use and peer review) and guidance for
peer-review of such work [1]. COPR called for applica-
tion of the values and frameworks within the US but
noted that the distinction between international and
domestic work, and work with communities in developed
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sidering the principles and guidelines for community
engagement.
Lavery and colleagues offered a set of guidelines in
2010 derived from their empirical work on community
engagement [38]. They outlined a set of ‘points to con-
sider’ that provide practical guidance on community
engagement in international research. These may be
viewed as steps on the path to achieving ethical goals via
community engagement, for example, characterizing and
building knowledge of communities; ensuring the purpose
and goals of the research are clear to the community;
identifying, mobilizing and developing relevant attitudes
about the proposed research; and ensuring adequate op-
portunities and respect for dissenting opinions.
In 2014 the Human Heredity and Health (H3Africa)
Consortium posted Guidelines for Community Engagement
in support of their mission to foster genomic research ex-
pertise in Africa as a tool for addressing health inequities.
The guidelines identified community engagement goals
focused on securing the support of the community for a
research project, improving understanding of the research
process, and soliciting views and inputs of community
members on aspects of the research [39] (p. 9).
From ethical goals to evaluation of practice
An oft-cited concern with community engagement in
research is the difficulty in assessing the effectiveness
of community engagement in general, or of practices
considered to be community engagement in particular
[40]. In order to assess effectiveness, however, the de-
sired goal needs to be clearly defined since it provides a
logical foundation for developing appropriate indicators
of success. Thus, evaluation of community engagement
is challenged by the diversity of ethical goals attributed
to it even among closely related guidance documents.
For example, while there is considerable overlap between
the Good Participatory Practices document first devel-
oped by UNAIDS/AVAC for biomedical HIV prevention
research (GPP-HIV) and subsequently adapted by CPTR
for TB clinical trials research (GPP-TB), they differ with
regard to the framing of ethical goals (Table 1). It can be
argued that a diversity of ethical goals is needed in order
for community engagement to be responsive to the con-
textual nuances of both the research and the setting
where it takes place. Consequently, this would place
obvious limitations on the generalizability of any given
evaluation design. It could also be argued that a core set
of generic ethical goals exist across all community en-
gagement contexts for research [24].
A further limitation in the literature and in existing
guidelines is the use of community engagement to
describe highly varied practices, for which different
ethical standards may exist. This stems in part from theuse of “community” to describe a broad range of group-
ings of individuals, from local communities to disease
communities to broader social groupings, such as racial
or ethnic groups and society as a whole [1, 21, 20]. In
this regard, the GPP-HIV and GPP-TB documents are
noteworthy in that they explicitly address the role of
stakeholders at multiple levels from the local to the glo-
bal. Stakeholders may coalesce into a variety of commu-
nities, some of which overlap and others that are highly
distinct.
In order to understand how well community engagement
in research is working, standard and reliable measures are
needed to gauge its success. Some measures have been
developed for community engagement broadly, and for
community-based participatory research in particular,
though they are few and the evidence generated to date is
thin [41, 42]. Most often, evaluation focuses on the process
of engagement and the contribution of engagement to suc-
cessful research implementation; no widely available re-
sources have yet been developed to explicitly evaluate how
and whether specific community engagement practices
lead to enhanced ethical outcomes in research.
Some instructive efforts are underway to evaluate the
impact of community engagement on research practice.
A study that used surveys to assess the acceptability
of exception from informed consent for research in
emergency settings found that interactive community
consultations resulted in significantly higher accepta-
bility and higher level recall of study content than non-
interactive consultations [43]. Approaches to evaluating
community engagement activities were briefly described
in the H3Africa guidelines including use of theory-
based methodology, monitoring participation at events
and meetings, documentation to track discussions, and
use of interviews, focus groups and surveys [39]. An
example informing the H3Africa guidelines was the use
of qualitative research to evaluate the informed consent
process, including a community engagement component,
for malaria-related genetics research in Ghana [44]. More
recently, the first author of this paper (MacQueen) is lead-
ing a project to develop and pilot an evaluation framework
for GPP-TB [45]. The data emerging from these and
similar efforts will help inform deliberations about
methods of evaluation and identify effective, ineffective, and
potentially detrimental or harmful methods of engagement.
As a step toward developing an evaluation framework
specific to the ethical goals of community engagement,
Table 2 categorizes the ethical goals of community en-
gagement in research that are depicted in Table 1. These
ethical goals provide a starting point for asking what
would constitute evidence that community engagement
practices contribute to the achievement of a particular
goal. Potential indicators reflective of the kind of evidence
that would need to be generated to show that particular
Table 2 Potential indicators for evaluating the contribution of community engagement (CE) to ethical goals
Ethical goal Potential indicators
Broadly protect communities in research • Procedures developed through CE exist to investigate events that have
been reported indirectly, such as through a third party, taking account
of confidentiality issues [14]
Weijer and Emanuel, 2000 [20]; Dickert and Sugarman, 2005 [21];
King et al., 2014 [24]
• Procedures developed through CE exist for reporting social harms, and
whether these are to be reported to sponsors, ethics committees, and
regulatory bodies if not specifically required by them [14]
• Documentation that stakeholders reflective of the potential reach of the
research are identified and actively engaged, beyond individual research
participants [24]
Minimize the possibility of exploitation • Procedures developed through CE exist to ensure community members
know where the research is being conducted and by whom [3]
Emanuel et al., 2004 [9]; Tindana et al., 2007 [6]; Critical Path to TB
Drug Regimens, 2012 [15]
• Documentation of use of appropriate mechanisms to ensure community
members understand research concepts (e.g., the difference between
research and clinical care) [3]
Increase the likelihood that the research will generate fair benefits
locally
• Evidence that CE empowered stakeholders to develop systems that are
useful to the community, build local capacity and gain control over their
lives [54]
Emanuel et al., 2004 [9]; Dickert and Sugarman, 2005 [21]; Nuffield
Council of Bioethics, 2005 [53]; Ahmed and Palermo, 2010 (COPR) [1];
UNAIDS and AVAC, 2011 [14]
• Evidence that community members used the knowledge gained
through CE to improve community members’ health and well-being [1]
• Research benefits identified during CE are demonstrated to accrue to
research participants and participant communities [1]
Ensure awareness of and respect for cultural differences • Evidence that researchers and research staff are aware of cultural
differences relevant to the research and have established procedures
that respect those differences and allow for them in research [24]
Emanuel et al., 2004 [9]; Tindana et al., 2007 [6]; King et al., 2014 [24] • Evidence that community members feel the research procedures and
process was/is respectful to their culture [24]
• Evidence of on-going relationships and open-ended discussions with
key stakeholders regarding the research and whether it is respectful of
cultural differences [24]
Ensure respect for recruited participants and study populations • Evidence that trust between communities and investigators increases
following implementation of CE [1]
Emanuel et al., 2004 [9]; Nuffield Council of Bioethics, 2005 [53]; Ahmed
and Palermo, 2010 (COPR) [1]; King et al., 2014 [24]
• Evidence of listening to, acknowledging, and being responsive to
stakeholders [24]
Legitimacy of the engagement process • Documentation of who in a community is engaged in deliberation and
discussion about the research and the extent to which they represent
the views of the larger community and relevant minority groups within
communities [24]
Dickert and Sugarman, 2005 [21]; UNAIDS and AVAC, 2011 [14]; King
et al., 2014 [24]
• Processes are in place to air disagreements and discuss the concerns
and interests of the stakeholder community [24]
• Documentation of clearly articulated goals for CE and tools for tracking
progress in achieving those goals [24]
Partners share responsibility for the conduct of the research • CAB provides documented feedback on the protocol, consent materials
and/or recruitment materials [3]
Dickert and Sugarman, 2005 [21]; Ahmed and Palermo, 2010 (COPR) [1] • Documentation that community members share suggestions for
research with researchers or are comfortable with the proposed
approach [3]
• Documentation that researchers and staff respond to community input [3]
• Documentation that communities participate in research throughout
the entire process, including determining the importance of the
problem, assessing the value of the research and conducting the study
[54, 9]
• Documentation of substantive community contributions to the design
and evaluation of the informed consent process [54]
• Documentation of substantive CAB member participation on protocol
development teams and scientific committees [3]
• Procedures are in place to actively probe participants and encourage
reporting of social harms [14]
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Table 2 Potential indicators for evaluating the contribution of community engagement (CE) to ethical goals (Continued)
• Documentation that CAB meeting(s) are held with community
stakeholders to discuss study design, eligibility, and implementation [3]
• Documentation that CAB meetings are held with researchers and
research staff to discuss research results and that the wider community
is informed of research results [3, 9]
Minimize community disruption • Evidence that conflicts, misunderstandings, and criticisms are minimized
or prevented through CE [1]
Tindana et al., 2007 [6]
Ensure that disparities, inequalities and stigma are not inadvertently
replicated or reinforced
• Evidence of changed norms and behaviors around disease-related
stigma in the community due to CE [54]
Tindana et al., 2007 [6]; Critical Path to TB Drug Regimens, 2012 [15] • Evidence that traditionally underserved communities increase their
power as a result of CE [1]
• Evidence that financial and other rewards of research identified through
CE are shared fairly [9]
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particular ethical goals are then identified. Ethical goal
statements such as those included in Table 2 could be
used to develop more detailed logic models commonly
used in public health to describe strategies, inputs, out-
comes, and impacts [46, 47]. The logic models, in turn,
would support systematic evaluation of the contribution
of community engagement practices to the broad range of
ethical claims being made. Such an approach would help
to strengthen the effectiveness of practice, identify areas in
need of strengthening, and ensure that resources are
directed toward activities that enhance achievement of
clearly articulated ethical goals. Conversely, if specific eth-
ical goals cannot be achieved via community engagement
in practice, conceptual work regarding such goals should
be reconsidered in light of the emerging data.
While Table 2 points toward the development of an
evaluation framework for community engagement, the
next steps must be done with considerable care. For ex-
ample, it is challenging to reconcile the inherent com-
plexity of the multiple layers of social embeddedness
described in the GPP documents with the requirements
of most evaluation models. Community engagement is
meant to be a dynamic process that is imbued with feed-
back loops that result in adaptive change by stakeholders
and transformation of the relationship context. Such
challenges can be seen in a post-hoc evaluation of the
community engagement program of the FEM-PrEP pre-
exposure prophylaxis trial for HIV prevention among
African women, which situated and assessed activities
in the context of the 2011 GPP-HIV guidelines [48]. A
process evaluation of community engagement for a
paediatric randomized controlled malaria vaccine trial at
three sites in Kilifi, Kenya further illustrates the need for
evaluation aligned with iterative and evolving interac-
tions among all stakeholders inclusive of researchers
[49]. To be useful and informative, evaluation must
move beyond a simple cause-effect framing of “does
community engagement work?”Two evaluation approaches appear to be promising in
this regard. The theory of change approach makes expli-
cit the presumed pathways by which a program may lead
to desired goals [50, 51]. This in turn helps in identifying
indicators, causes, and outcomes to include in the evalu-
ation as well as appropriate methods to determine if the
presumed pathways hold up as theorized. The realist
evaluation approach takes a somewhat different tack by
asking “what works for whom in what circumstances
and in what respects, and how?” [51] Here the emphasis
is on elucidating the relationships among context, change
mechanisms, and outcomes to identify factors that may
affect both the intervention and its outcome. Realist
evaluation presumes repeated iterations between theory
development and empirical investigation at the micro
level [52]. Theory of change and realist evaluation are
potentially complementary approaches that show prom-
ise but are also relatively new and have weaknesses with
regard to methodological clarity [51, 50]. A richer
exploration of the application of logic models, theory of
change, and realistic evaluation to the ethical aspects of
community engagement is needed.
Summary
There is a critical need to enhance work in evaluating
community engagement—to ensure that the work on the
ground reflects the intentions expressed in the guide-
lines, and also to investigate the contribution of specific
community engagement practices for making research
responsive to community needs and concerns. We en-
courage further research in this area, and recommend
that research groups nest evaluation mechanisms in
their community engagement practices to be able to de-
velop a refined and evidence-based understanding of
what aspects of current community engagement work is
effective, and to identify areas where further work is
needed. Evaluation designs should reflect explicit state-
ments about the goals of the community engagement
work undertaken. This will also help in evolving a set of
MacQueen et al. BMC Medical Ethics  (2015) 16:44 Page 8 of 9best practices in community engagement that can be
replicated across various settings. A coherent set of com-
munity engagement goals and indicators would also
assist research ethics committees in deciding the minimal
community engagement practices required of those
applying for ethics review and approval.
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